𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma

✍ Scribed by Se Hoon Park; Yeon Ho Park; Jeong Nam Lee; Soo-Mee Bang; Eun Kyung Cho; Dong Bok Shin; Jae Hoon Lee


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
85 KB
Volume
106
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Expanded phase II trial of gemcitabine a
✍ Rachel P. Riechelmann; Carol A. Townsley; Sheray N. Chin; Gregory R. Pond; Jenni πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. A phase 2 trial of gemcitabine and capecitabine (GemCap) in patients with advanced biliary cancer led to an objective response in approximately 30% of patients and a median survival of 14 months. In the current study, the authors report further efficacy data of a larger